NANOBIOTIX Announces Closing of Global Offering : vimarsana.

PARIS and CAMBRIDGE, Mass., Nov. 07, 2023 -- NANOBIOTIX , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer,...

Related Keywords

Canada , Cambridge , Cambridgeshire , United Kingdom , France , New York , United States , Boston , Massachusetts , Paris , France General , French , Ligia Vela Reid , Pierre Louis Germain , Brandon Owens , Euronext , Jjdc Inc , Company License Agreement , Equity Syndicate Department , Syndicate Department , Investor Relations Department , Equity Syndicate Prospectus Department , Company Ordinary , Nasdaq , Leerink Partners , Communications Department , French Ministry Of Economy , Exchange Commission , Financial Services , American Depositary Shares , Underwriter Option , European Offering , Johnson Innovation , Securities Act , Placement Amount , French Ministry , Regulatory Cap , Concurrent Private Placement , Global Offering , Remaining Placement Amount , Janssen Pharmaceutica , License Agreement , Guggenheim Securities , Nasdaq Global Select Market , Ordinary Shares , Euronext Paris , New York City , Ulysse Communication , Private Securities Litigation Reform Act , Annual Report , French Monetary , Financial Code , French Commercial Code , European Economic Area , Relevant Member State , Prospectus Regulation , Markets Act , Financial Promotion , Markets ,